METTL1-mediated MG Methylation Maintains Pluripotency in Human Stem Cells and Limits Mesoderm Differentiation and Vascular Development

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2020 Jul 24

PMID 32698871

Citations 42

Authors

Yujie Deng

Zhongyang Zhou

Weidong Ji

Shuibin Lin

Min Wang

Affiliations

Soon will be listed here.

Abstract

Background: 7-Methylguanosine (mG) is one of the most conserved modifications in nucleosides within tRNAs and rRNAs. It plays essential roles in the regulation of mRNA export, splicing, and translation. Recent studies highlighted the importance of METTL1-mediated mG tRNA methylome in the self-renewal of mouse embryonic stem cells (mESCs) through its ability to regulate mRNA translation. However, the exact mechanisms by which METTL1 regulates pluripotency and differentiation in human induced pluripotent stem cells (hiPSCs) remain unknown. In this study, we evaluated the functions and underlying molecular mechanisms of METTL1 in regulating hiPSC self-renewal and differentiation in vivo and in vitro.

Methods: By establishing METTL1 knockdown (KD) hiPSCs, gene expression profiling was performed by RNA sequencing followed by pathway analyses. Anti-mG northwestern assay was used to identify mG modifications in tRNAs and mRNAs. Polysome profiling was used to assess the translation efficiency of the major pluripotent transcription factors. Moreover, the in vitro and in vivo differentiation capacities of METTL1-KD hiPSCs were assessed in embryoid body (EB) formation and teratoma formation assays.

Results: METTL1 silencing resulted in alterations in the global mG profile in hiPSCs and reduced the translational efficiency of stem cell marker genes. METTL1-KD hiPSCs exhibited reduced pluripotency with slower cell cycling. Moreover, METTL1 silencing accelerates hiPSC differentiation into EBs and promotes the expression of mesoderm-related genes. Similarly, METTL1 knockdown enhances teratoma formation and mesoderm differentiation in vivo by promoting cell proliferation and angiogenesis in nude mice.

Conclusion: Our findings provided novel insight into the critical role of METTL1-mediated mG modification in the regulation of hiPSC pluripotency and differentiation, as well as its potential roles in vascular development and the treatment of vascular diseases.

Citing Articles

Deciphering the secret codes in N-methylguanosine modification: Context-dependent function of methyltransferase-like 1 in human diseases.

Fang H, He J, Du D, Wang X, Xu X, Lu L Clin Transl Med. 2025; 15(2):e70240.

PMID: 39979979 PMC: 11842222. DOI: 10.1002/ctm2.70240.

N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential.

Wu Q, Fu X, Liu G, He X, Li Y, Ou C J Hematol Oncol. 2025; 18(1):12.

PMID: 39881381 PMC: 11780989. DOI: 10.1186/s13045-025-01665-7.

RNA modifications in cancer.

Wu H, Chen S, Li X, Li Y, Shi H, Qing Y MedComm (2020). 2025; 6(1):e70042.

PMID: 39802639 PMC: 11718328. DOI: 10.1002/mco2.70042.

Transcriptome-wide mapping of internal mRNA N-methylguanosine in sporulated and unsporulated oocysts of Eimeria tenella reveals stage-specific signatures.

Fan Q, Wang Z, Wang J, Wang Y, Zhang Z, Yu L Parasit Vectors. 2024; 17(1):491.

PMID: 39605027 PMC: 11603632. DOI: 10.1186/s13071-024-06580-3.

RNA modifications: emerging players in the regulation of reproduction and development.

Wen J, Zhu Q, Liu Y, Gou L Acta Biochim Biophys Sin (Shanghai). 2024; 57(1):33-58.

PMID: 39574165 PMC: 11802351. DOI: 10.3724/abbs.2024201.

References

Bulic-Jakus F, Bojanac A, Juric-Lekic G, Vlahovic M, Sincic N . Teratoma: from spontaneous tumors to the pluripotency/malignancy assay. Wiley Interdiscip Rev Dev Biol. 2015; 5(2):186-209. DOI: 10.1002/wdev.219. View

Stadtfeld M, Hochedlinger K . Induced pluripotency: history, mechanisms, and applications. Genes Dev. 2010; 24(20):2239-63. PMC: 2956203. DOI: 10.1101/gad.1963910. View

Dovey O, Foster C, Cowley S . Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc Natl Acad Sci U S A. 2010; 107(18):8242-7. PMC: 2889513. DOI: 10.1073/pnas.1000478107. View

Mohammadnia A, Yaqubi M, Pourasgari F, Neely E, Fallahi H, Massumi M . Signaling and Gene Regulatory Networks Governing Definitive Endoderm Derivation From Pluripotent Stem Cells. J Cell Physiol. 2016; 231(9):1994-2006. DOI: 10.1002/jcp.25308. View

Lengner C, Welstead G, Jaenisch R . The pluripotency regulator Oct4: a role in somatic stem cells?. Cell Cycle. 2008; 7(6):725-8. DOI: 10.4161/cc.7.6.5573. View

Lee C, Bendriem R, Wu W, Shen R . 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders. J Biomed Sci. 2017; 24(1):59. PMC: 5563385. DOI: 10.1186/s12929-017-0362-8. View

Kuppusamy K, Sperber H, Ruohola-Baker H . MicroRNA regulation and role in stem cell maintenance, cardiac differentiation and hypertrophy. Curr Mol Med. 2013; 13(5):757-64. PMC: 3898432. DOI: 10.2174/1566524011313050007. View

Wu S, Hochedlinger K . Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol. 2011; 13(5):497-505. PMC: 3617981. DOI: 10.1038/ncb0511-497. View

Coutu D, Galipeau J . Roles of FGF signaling in stem cell self-renewal, senescence and aging. Aging (Albany NY). 2011; 3(10):920-33. PMC: 3229969. DOI: 10.18632/aging.100369. View

10.

Lee D, Su J, Ang Y, Carvajal-Vergara X, Mulero-Navarro S, Pereira C . Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling. Cell Stem Cell. 2012; 11(2):179-94. PMC: 3413175. DOI: 10.1016/j.stem.2012.05.020. View

11.

Wu M, Chen G, Li Y . TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 2016; 4:16009. PMC: 4985055. DOI: 10.1038/boneres.2016.9. View

12.

Qu Q, Li D, Louis K, Li X, Yang H, Sun Q . High-efficiency motor neuron differentiation from human pluripotent stem cells and the function of Islet-1. Nat Commun. 2014; 5:3449. DOI: 10.1038/ncomms4449. View

13.

Ren R, Ocampo A, Liu G, Izpisua Belmonte J . Regulation of Stem Cell Aging by Metabolism and Epigenetics. Cell Metab. 2017; 26(3):460-474. DOI: 10.1016/j.cmet.2017.07.019. View

14.

Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M . Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med. 2000; 6(2):88-95. PMC: 1949933. View

15.

Ding J, Xu H, Faiola F, Maayan A, Wang J . Oct4 links multiple epigenetic pathways to the pluripotency network. Cell Res. 2011; 22(1):155-67. PMC: 3252465. DOI: 10.1038/cr.2011.179. View

16.

Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W . Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019; 394(10204):1145-1158. PMC: 6891889. DOI: 10.1016/S0140-6736(19)30427-1. View

17.

Wu Y, Zhou C, Yuan Q . Role of DNA and RNA N6-Adenine Methylation in Regulating Stem Cell Fate. Curr Stem Cell Res Ther. 2017; 13(1):31-38. DOI: 10.2174/1574888X12666170621125457. View

18.

Flaherty E, Brennand K . Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms. Brain Res. 2015; 1655:283-293. PMC: 4865445. DOI: 10.1016/j.brainres.2015.11.009. View

19.

Ingolia N, Lareau L, Weissman J . Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell. 2011; 147(4):789-802. PMC: 3225288. DOI: 10.1016/j.cell.2011.10.002. View

20.

Subramanian A, Guo B, Marsden M, Galic Z, Kitchen S, Kacena A . Macrophage differentiation from embryoid bodies derived from human embryonic stem cells. J Stem Cells. 2010; 4(1):29-45. PMC: 3476843. DOI: jsc.2009.4.1.29. View